Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Mol Genet Metab. 2014 Jul 16;113(0):14–26. doi: 10.1016/j.ymgme.2014.07.009

Table 7.

Region 7 newborn screening incidence data for selected metabolic conditions from January 1, 2001 – December 31, 2010

Newborn Screening Programs in Region 7
Condition Alaskaa Californiab Hawaiic Idahod Oregone Washingtonf
Cases Births Cases Births Cases Births Cases Births Cases Births Cases Births
3-MCC 1 86,374 58 2,997,046 3 149,783 1 184,644 8 428,110 0 220,866
ASA 0 86,374 7 2,997,046 1 149,783 1 184,644 5 428,110 0 220,866
BIO 1 106,126 25 1,875,211 1 184,422 1 244,254 4 474,310 4 605,494
Partial BIO 3 106,126 33 1,875,211 5 184,422 8 244,254 15 474,310 16 605,494
BKT 0 86,374 2 2,997,046 0 149,783 0 184,644 0 288,758 1 220,866
CBL A,B 0 44,851 6 2,997,046 0 149,783 0 184,644 0 428,110 0 220,866
CUD 0 86,374 41 2,997,046 0 149,783 2 184,644 2 428,110 0 220,866
CIT 0 86,374 10 2,997,046 0 149,783 2 184,644 1 428,110 0 220,866
GA-1 3 86,374 24 2,997,046 1 149,783 3 184,644 2 428,110 3 220,866
GALT 11 106,126 59 5,417,932 2 184,422 4 225,254 5 474,310 7 843,161
HCY 0 86,374 2 2,997,046 0 167,295 0 205,093 1 382,057 1 605,494
HMG 0 86,374 1 2,997,046 0 149,783 0 184,644 0 428,110 0 220,866
IVA 0 86,374 21 2,997,046 2 149,783 1 184,644 1 428,110 0 220,866
LCHADD 0 86,374 6 2,997,046 0 149,783 1 184,644 4 428,110 0 220,866
MCADD 9 86,374 115 2,997,046 4 149,783 16 184,644 28 428,110 32 605,494
MCD 0 86,374 3 2,997,046 1 149,783 0 184,644 0 288,758 0 220,866
MSUD 2 106,126 21 2,997,046 2 184,422 2 225,254 0 474,310 2 605,494
MUT 0 86,374 44 2,997,046 0 149,783 3 184,644 5 428,110 1 427,302
PKU 7 106,126 171 5,417,932 1 184,422 15 225,254 20 474,310 52 843,161
PKU Variant 0 106,126 139 5,417,932 1 184,422 1 225,254 6 474,310 31 843,161
PROP 2 86,374 6 2,997,046 0 149,783 1 184,644 0 428,110 0 220,866
TFP 0 86,374 2 2,997,046 0 149,783 0 184,644 0 288,758 0 220,866
TYR-I 1 86,374 10 2,997,046 0 149,783 0 184,644 0 428,110 0 220,866
VLCADD 3 86,374 37 2,997,046 7 149,783 3 184,644 3 428,110 5 220,866
a

Data began: Jan 1, 2003 for all except BIO, CBL A,B, GALT, MSUD, PKU; Jan 1, 2007 for CBL A,B

b

Data began: Jul 11, 2005 for all except BIO, GALT, PKU; Jul 16, 2007 for BIO

c

Data began: Jan 1, 2002 for HCY; Jan 1, 2003 for all except BIO, GALT, HCY, MSUD, PKU

d

Data began: Jan 1, 2002 for HCY; Jan 1, 2003 for all except BIO, GALT, HCY, MSUD, PKU

e

Data began: Jan 1, 2002 for all except BIO, BKT, GALT, HCY, MCD, MSUD, PKU, TFP; Jan 1, 2003 for HCY; Jan 1, 2005 for BKT, MCD, TFP

f

Data began: Jan 1, 2004 for BIO, HCY, MCADD, MSUD; Jul 1, 2008 for all except BIO, GALT, HCY, MCADD, MSUD, PKU

Abbreviations: 3-MCC, 3-Methylcrotonyl-CoA carboxylase deficiency; ASA, Argininosuccinic aciduria; BIO, biotinidase; BKT, Beta-ketothiolase deficiency; CBL A,B, methylmalonic acidemia (cobalamin A and B); CIT, Citrullinemia; CUD, Carnitine uptake defect; GA-1, Glutaric acidemia type I; GALT, Galactosemia transferase deficiency (classical galactosemia); HCY, Homocystinuria; HMG, 3-Hydroxy 3-methyl glutaric aciduria; IVA, Isovaleric acidemia; LCHADD, Long-chain L-3- hydroxyacyl-CoA dehydrogenase deficiency; MCADD, Medium-chain acyl-CoA dehydrogenase deficiency; MCD, Multiple carboxylase deficiency; MSUD, Maple syrup (urine) disease; MUT, Methylmalonic academia (methylmalonyl-CoA mutase deficiency); PKU, Phenylketonuria; PROP, Propionic acidemia; TFP, Trifunctional protein deficiency; TYR-I, Tyrosinemia type I; VLCADD, Very long-chain acyl-CoA dehydrogenase deficiency